Methylphenidatedrug info
24 HR methylphenidate hydrochloride 40 MG Chewable Extended Release Oral Tablet [QuilliChew]
What it is used for
QuilliChew ER is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Limitations of Use The use of QuilliChew ER is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage. QuilliChew ER is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Limitations of Use The use of QuilliChew ER is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective April 8, 2026. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
Description
QuilliChew ER (methylphenidate hydrochloride extended-release chewable tablets) contains methylphenidate and methylphenidate hydrochloride. QuilliChew ER is available in three dosage strengths - 20 mg, 30 mg and 40 mg. The dosage strengths are expressed in terms of methylphenidate hydrochloride equivalents; however only 15% of methylphenidate is present as methylphenidate hydrochloride salt. The remaining 85% is present as methylphenidate complexed with sodium polystyrene sulfonate. QuilliChew ER contains the equivalent of approximately 30% immediate-release and 70% extended-release methylphenidate. Dosage Strength Dosage strength in terms of equivalent amount of methylphenidate HCl Dosage strength in terms of equivalent amount of methylphenidate Actual methylphenidate HCl content Actual Methylphenidate content 20 mg 20 mg 17.30 mg 3.00 mg 14.70 mg 30 mg 30 mg 25.95 mg 4.50 mg 22.05 mg 40 mg 40 mg 34.59 mg 6.00 mg 29.40 mg The QuilliChew ER extended-release chewable tablets are cherry flavored. Methylphenidate is a central nervous system (CNS) stimulant. The chemical name is methyl α- phenyl-2-piperidineacetate.
Figure 1: Methylphenidate C 14 H 19 NO 2 Mol. Wt. 233.31 QuilliChew ER also contains the following inactive ingredients: aspartame, cherry flavor, citric acid, crospovidone, D&C red #30 (for 30 mg strength), D&C red #7 (for 40 mg strength), guar gum, magnesium stearate, mannitol, microcrystalline cellulose, polyvinyl acetate, polyvinyl alcohol, povidone, silicon dioxide, sodium polystyrene sulfonate, talc, triacetin, xanthan gum. figure1
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective April 8, 2026. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance